Tag: Immunotherapy
Vedolizumab Beats Adalimumab for Ulcerative Colitis Remissions
But not for corticosteroid-free clinical remission; also, ustekinumab superior to placebo
Electronic Nose Analysis May Predict Response to Anti-PD-1 Therapy in NSCLC
Initial breath analysis predicts individual treatment response to anti-PD-1 therapy at three months
Allergy Immunotherapy May Decrease Asthma Progression
Findings strongest for youngest patients with incident asthma treated in routine care
Underused Drug Combo May Up Survival in Lung Transplant
No antibody induction therapy with sirolimus plus tacrolimus associated with maximal survival
SAVED Score Can Predict Risk for VTE in Multiple Myeloma
Score outperforms current NCCN guidelines for MM patients receiving immunomodulatory therapy
Chemoimmunotherapy Regimen Approved to Treat DLBCL
Polivy approved in combination with bendamustine, rituximab for diffuse large B-cell lymphoma
Peanut Oral Immunotherapy May Up Allergic Reaction Risk
Increase seen in anaphylaxis risk, anaphylaxis frequency, epinephrine use with oral immunotherapy
Peanut Oral Immunotherapy Appears Safe for Preschool-Age Children
Most children reached maintenance; 0.4 percent had severe adverse reaction
Older Patients With Crohn Disease May Benefit From Early Combo Tx
Early step-up combo therapy includes tumor necrosis factor-α antagonist plus an antimetabolite
Almost Three-Quarters of Allergists Have Prescribed SLIT
Main barrier to sublingual immunotherapy is limitation of treating only one allergen
